231 related articles for article (PubMed ID: 21232675)
21. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
22. Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine.
Hirakawa R; El-Bizri N; Shryock JC; Belardinelli L; Rajamani S
Neuropharmacology; 2012 Jun; 62(7):2251-60. PubMed ID: 22313527
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Sicouri S; Blazek J; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):371-9. PubMed ID: 22407414
[TBL] [Abstract][Full Text] [Related]
24. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
Sicouri S; Burashnikov A; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):88-95. PubMed ID: 19952329
[TBL] [Abstract][Full Text] [Related]
25. Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.
Moreno JD; Yang PC; Bankston JR; Grandi E; Bers DM; Kass RS; Clancy CE
Circ Res; 2013 Sep; 113(7):e50-e61. PubMed ID: 23897695
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
27. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine: clinical applications and therapeutic basis.
Hawwa N; Menon V
Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347
[TBL] [Abstract][Full Text] [Related]
29. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
30. Aging-associated susceptibility to stress-induced ventricular arrhythmogenesis is attenuated by tetrodotoxin.
Holmuhamedov EL; Chakraborty P; Oberlin A; Liu X; Yousufuddin M; Shen WK; Terzic A; Jahangir A
Biochem Biophys Res Commun; 2022 Oct; 623():44-50. PubMed ID: 35870261
[TBL] [Abstract][Full Text] [Related]
31. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
Wang S; Radhakrishnan J; Ayoub IM; Kolarova JD; Taglieri DM; Gazmuri RJ
J Appl Physiol (1985); 2007 Jul; 103(1):55-65. PubMed ID: 17431086
[TBL] [Abstract][Full Text] [Related]
32. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
Song Y; Shryock JC; Belardinelli L
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2031-9. PubMed ID: 18310511
[TBL] [Abstract][Full Text] [Related]
33. Effect of autonomic influences to induce triggered activity in muscular sleeves extending into the coronary sinus of the canine heart and its suppression by ranolazine.
Sicouri S; Belardinelli L; Antzelevitch C
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):230-238. PubMed ID: 30302862
[TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.
Wu L; Shryock JC; Song Y; Li Y; Antzelevitch C; Belardinelli L
J Pharmacol Exp Ther; 2004 Aug; 310(2):599-605. PubMed ID: 15031300
[TBL] [Abstract][Full Text] [Related]
35. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
Aidonidis I; Doulas K; Hatziefthimiou A; Tagarakis G; Simopoulos V; Rizos I; Tsilimingas N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):94-101. PubMed ID: 22872232
[TBL] [Abstract][Full Text] [Related]
36. Ranolazine improves diastolic function in spontaneously hypertensive rats.
Williams S; Pourrier M; McAfee D; Lin S; Fedida D
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H867-81. PubMed ID: 24464752
[TBL] [Abstract][Full Text] [Related]
37. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
38. Antiepileptic activity of preferential inhibitors of persistent sodium current.
Anderson LL; Thompson CH; Hawkins NA; Nath RD; Petersohn AA; Rajamani S; Bush WS; Frankel WN; Vanoye CG; Kearney JA; George AL
Epilepsia; 2014 Aug; 55(8):1274-83. PubMed ID: 24862204
[TBL] [Abstract][Full Text] [Related]
39. Atrial Fibrillation Initiated by Early Afterdepolarization-Mediated Triggered Activity during Acute Oxidative Stress: Efficacy of Late Sodium Current Blockade.
Pezhouman A; Cao H; Fishbein MC; Belardinelli L; Weiss JN; Karagueuzian HS
J Heart Health; 2018 Apr; 4(1):. PubMed ID: 30393761
[TBL] [Abstract][Full Text] [Related]
40. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
